Anti-cancer drugs and uses relating thereto for metastatic malignant melanoma and other cancers
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 4, 2012
Grant Date -
Mar 18, 2010
app pub date -
Sep 15, 2009
filing date -
Sep 15, 2008
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention discloses triazene analogs of the general formula (I) and formula (II), their tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, and pharmaceutically acceptable salts thereof for the metastatic malignant melanoma and other cancers including but not limited to lymphomas, sarcomas, carcinomas, and gliomas.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully